Cargando…
The oleocanthal-based homovanillyl sinapate as a novel c-Met inhibitor
The hepatocyte growth factor (HGF)/mesenchymal-epithelial transition factor (c-Met) signaling axis has gained considerable attention as an attractive molecular target for therapeutic blockade of cancer. Inspired by the chemical structure of S (−)-oleocanthal, a natural secoiridoid from extra-virgin...
Autores principales: | Mohyeldin, Mohamed M., Akl, Mohamed R., Ebrahim, Hassan Y., Dragoi, Ana Maria, Dykes, Samantha, Cardelli, James A., El Sayed, Khalid A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078011/ https://www.ncbi.nlm.nih.gov/pubmed/27086914 http://dx.doi.org/10.18632/oncotarget.8681 |
Ejemplares similares
-
Olive Phenolics as c-Met Inhibitors: (-)-Oleocanthal Attenuates Cell Proliferation, Invasiveness, and Tumor Growth in Breast Cancer Models
por: Akl, Mohamed R., et al.
Publicado: (2014) -
Isothiocyanatostilbenes as novel c-Met inhibitors
por: Gray, Alana L., et al.
Publicado: (2015) -
(−)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo
por: Siddique, Abu Bakar, et al.
Publicado: (2019) -
(−)-Oleocanthal as a Dual c-MET-COX2 Inhibitor for the Control of Lung Cancer
por: Siddique, Abu Bakar, et al.
Publicado: (2020) -
Araguspongine C Induces Autophagic Death in Breast Cancer Cells through Suppression of c-Met and HER2 Receptor Tyrosine Kinase Signaling
por: Akl, Mohamed R., et al.
Publicado: (2015)